Federico Montealegre, Phd, DVM

Department of Microbiology

Research Info

• Clinical Research in lung diseases and cancer
• Immunochemical characterization of allergens of the house dust mite       "Blomia Tropicalis"
• Epidemiology and indoor risk factors of asthma and atopic dermatitis
• Detection and quantitation of indoor environmental irritants
• Health care for pulmonary diseases (asthma)       

• SAS30021- Principal Investigator- A Stratified, Randomized, Double Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Safety and Efficacy of the Fluticasone Propionate/Salmeterol Diskus Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate Diskus 100 mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma. 
• SAM40027- Principal Investigator- Gaining Optimal Asthma Control (GOAL).  A Step-Up Comparison Of The Level Of Asthma Control Achieved With Salmeterol/ Fluticasone Propionate Combination Compared With Fluticasone Propionate Alone.
• SD-00400732- Sub-Investigator - A Safety And Efficacy Study Of Two Dosage Levels Of Pulmicort Respules (Budenoside Inhalation Suspension, 0.5 Or 1 Mg/Day) Versus Placebo In Infants Between Ages Of Six & Twelve Months With Mild To Moderate Asthma.